Paul Hastings, a leading global law firm, announced today that the firm represented Cequel Data Centers III, LLC, a data center operating company managed by an affiliate of Cequel III, LLC and owned by an affiliate of Cequel III, LLC and a consortium of private equity firms, in the acquisition of Baltimore Technology Park, a data center located in Baltimore, Maryland (more…)

www.paulhastings.com

|

Perkins Coie is pleased to announce that Allan E. Low has joined the firm’s San Francisco office as a partner in the Real Estate practice.  Low was most recently a partner at Nixon Peabody LLP (more…)

www.perkinscoie.com

|

International law firm McDermott Will & Emery today announced the appointment of A. Marisa Chun as a partner in the Firm’s Trial Practice Group, based in Silicon Valley (more…)

www.mwe.com

|

Goodwin Procter, a national Am Law 50 firm, announced today that Grant P. Fondo has joined the firm’s Silicon Valley office as a partner in its Securities Litigation & White Collar Defense Group. Fondo comes to Goodwin from the U.S. Attorney’s Office for the Northern District of California, where he served as an Assistant U.S. Attorney in its Criminal Division for nearly five years. He will focus on representing technology, life sciences and venture capital clients in a wide range of litigation and investigative matters (more…)

www.goodwinprocter.com

|

Douglas Bria has joined Littler Mendelson, P.C. (Littler), the world’s largest employment and labor law firm representing management, as a shareholder in the San Francisco office. Bria, previously a partner in Jackson Lewis LLP’s San Francisco office, has extensive experience in employment litigation matters, including class actions and complex litigation, e-Discovery, general employment litigation and wage and hour compliance. Bria’s arrival coincides with the addition of another former Jackson Lewis partner, JoAnna Brooks, who also joined Littler last week (more…)

www.littler.com

|

Cooley LLP announced today that it advised Spooky Cool Labs LLC in its acquisition by Zynga Inc. Spooky Cool Labs is a social gaming company focused on developing cutting edge social and mobile games (more…)

www.cooley.com

|

Leech Tishman is pleased to announce its expansion to the West Coast with the opening of its California office. The office, located in Pasadena, California, will be led by Alan M. Kindred and Ivan Posey, two renowned intellectual property lawyers with decades of  experience in trademark, copyright and patent prosecution, intellectual property litigation, as well as domestic and international business and trade matters. Accordingly, Leech Tishman adds this Intellectual Property Practice Group to its growing list of service offerings (more…)

leechtishman.com

|

Simpson Thacher represented the underwriters, led by BNP Paribas Securities Corp., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, in connection with the registered public offering of $600 million principal amount of 3.875% Senior Notes due 2023 of Agilent Technologies, Inc (more…)

www.stblaw.com

|

O’Melveny & Myers LLP represented MakerBot, a leader in desktop 3D printing, in its acquisition by Stratasys Ltd. MakerBot has agreed to merge with a subsidiary of Stratasys in a stock-for-stock transaction (more…)

www.omm.com

|

Kaufman Dolowich & Voluck LLP (KDV), a leading national law firm, today announced that Vincent S. Green, a trial attorney with 35 years of experience in both federal and state courts, has joined the firm as a partner in its Los Angeles office (more…)

kdvlaw.com

|

Davis Polk advised JPMorgan Chase Bank, N.A. as administrative agent, issuing lender and swing line lender in connection with the second amendment and restatement of its existing $150 million asset-based revolving credit facility for Tower Automotive Holdings USA, LLC. The facility will be used for general corporate purposes (more…)

www.davispolk.com

|

O’Melveny & Myers LLP represented Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) in its proposed public offering. The company, which develops medicines related to cancer treatment, plans to use the proceeds for research and development and general corporate purposes (more…)

www.omm.com

|